Related Experiment Videos

Effect of tranexamic acid on progress of experimental tumours and on DNA-synthesis

B Astedt, C Tropé

Experientia

|June 15, 1980

Abstract:

The fibrinolytic inhibitor tranexamic acid affects certain experimental tumours; it prolongs survival (Lewis lung adenocarcinoma), decreases tumour weight (C3H breast carcinoma), and inhibits ascitic production (AH 130 rat hepatoma). However, it does not significantly influence DNA-synthesis in cell suspensions prepared from the same tumours.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival.

European journal of gynaecological oncology·2016

The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome.

European journal of gynaecological oncology·2011

Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.

Gynecologic oncology·2011

Diagnosis and treatment of borderline ovarian neoplasms "the state of the art".

European journal of gynaecological oncology·2009

A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice.

Journal of clinical pathology·2009

Is the watch and wait approach adequate after comprehensive surgical staging in invasive stage I epithelial ovarian cancer? The Norwegian Radium Hospital experience.

European journal of gynaecological oncology·2009

See all related articles